首页> 外文期刊>Bone marrow transplantation >Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.
【24h】

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.

机译:大剂量或非清髓性同种异体造血细胞移植后血栓性微血管病变的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

The role of conditioning intensity on occurrence of thrombotic microangiopathy (TMA) after allogeneic hematopoietic cell transplantation (HCT) has remained unclear thus far. Here, we retrospectively compared the incidence of TMA in patients given allogeneic hematopoietic stem cells after either nonmyeloablative (n=176) or high-dose (n=111) conditioning. The 1-year cumulative incidence of TMA was 13% in nonmyeloablative recipients versus 15% in high-dose conditioning recipients (P=0.5). In multivariate Cox analysis, occurrence of grade 3-4 acute graft-versus-host disease (GVHD) (hazard ratio (HR)=2.3, P<0.001), older age (HR=1.01, P=0.045), and unrelated donors (HR=1.6, P=0.01) were each associated with a higher risk of TMA, whereas nonmyeloablative conditioning was associated with a lower risk of TMA (HR=0.6, P=0.01). We conclude that acute GVHD, age, donor type, and conditioning intensity might have a role in the physiopathology of TMA after allogeneic HCT.
机译:迄今为止,调节强度对异基因造血细胞移植(HCT)后血栓性微血管病(TMA)发生的作用尚不清楚。在这里,我们回顾性地比较了非清髓性(n = 176)或大剂量(n = 111)调理后接受异基因造血干细胞的TMA发生率。非清髓性接受者的TMA的1年累积发生率是13%,而高剂量条件接受者的TMA为1%(P = 0.5)。在多因素Cox分析中,发生3-4级急性移植物抗宿主病(GVHD)(危险比(HR)= 2.3,P <0.001),年龄较大(HR = 1.01,P = 0.045)和无关的供体(HR = 1.6,P = 0.01)分别与较高的TMA风险相关,而非清髓性调理与较低的TMA风险相关(HR = 0.6,P = 0.01)。我们得出结论,异基因HCT后,急性GVHD,年龄,供体类型和条件强度可能在TMA的生理病理中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号